Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Syrris Appointed as North American Distributor of Lara and Coflux Product Lines

Published: Monday, October 03, 2005
Last Updated: Tuesday, October 04, 2005
Bookmark and Share
Syrris will be exhibiting Lara and Coflux at the forthcoming Cambridge Healthcare Institute Process R&D Summit in Philadelphia.

Syrris Inc. has announced that it have been appointed distributors of the Lara Controlled Lab Reactor (CLR) and the Coflux reaction monitoring and calorimetry system in North America.

According to Syrris, Lara CLR is a flexible and modular chemical reactor that is both affordable and highly automated.

It can accommodate variable vessel size, ranging from 100ml to 5 litres, and it incorporates easy-to-use software which allows extensive reaction design and full data logging.

The Coflux (Constant Flux) system uses the Lara CLR software to gather real-time reaction data such as power and enthalpy change.

With minimal calibration, accurate temperature measurements are afforded through a thermal jacket comprising of numerous coolant tubes surrounding the reaction vessel.

Making the announcement, Richard Gray, Commercial Director said, “We have experienced great success with the Lara CLR and Coflux products and our expanding client base reaches across US, including major pharma companies such as GSK and Pfizer.”

He continued “this new appointment by Radleys ensures that customers in North America will receive the very best sales and technical support”.

Mark Radley, Managing Director of Radleys commented, “We’re confident Lara will offer significant benefits to customers in North America.”

“Syrris worked closely with us on the design and development of both Lara and Coflux, and so have great knowledge of these products and are in the ideal position to service the US market.”

Syrris will be exhibiting Lara and Coflux at the forthcoming Cambridge Healthcare Institute Process R&D Summit in Philadelphia from 24th-26th October.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Syrris Invites Chemists to Join Free Flow Chemistry Workshop in the US
Syrris is hosting a free flow chemistry workshop in Cambridge, Massachusetts, USA, on the 9th of May 2013.
Monday, April 22, 2013
Syrris Acclaimed for Latin American Presence
Extensive progress acknowledged following the opening of the Brazilian subsidiary.
Saturday, October 09, 2010
Syrris Announces Outstanding Success Following Expansion of Worldwide Operations
The Company has experienced strong 2010 start by opening its Brazilian subsidiary and new product launches.
Friday, July 16, 2010
Syrris to Host Technical Seminars in India for R&D Chemists
Applications-focused seminars to explore calorimetry, sonocrystallization and flow chemistry solutions.
Monday, May 10, 2010
Syrris Establishes Indian Subsidiary
Company expands its sales network and service support for all customers in India.
Monday, July 27, 2009
Syrris to Further Extend its Global Outreach with new Distributors Across Europe, Asia and the Middle East
Syrris has appointed three sales and customer support personnel and six distributors to support its new modular flow chemistry and synthesis systems.
Thursday, December 06, 2007
Academics Get to Test Flow Chemistry System for Free
Syrris has announced the winners of its competition to win the use of its new FRX300 flow chemistry system.
Monday, October 22, 2007
Win a Flow Chemistry System
Syrris is providing scientists with the opportunity to win one month’s free use of one of its FRX systems, the FRX300, including delivery, training and system support.
Monday, June 18, 2007
Syrris Announce new West Coast Office
To meet the growing Customer demand, Syrris expands its US sales and customer service team with the opening of an office in La Jolla, CA, to provide support for its modular flow chemistry and synthesis products.
Thursday, March 15, 2007
Buoyant Order Book Spurs Recruitment Drive at Syrris
Syrris to double sales force for its FRX and atlas as these systems demonstrate the success of the modular approach.
Tuesday, January 30, 2007
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos